AGP Picks
View all

European Morning Report
Provided by AGP

European Morning Report: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on European Morning Report.

August 2026

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30
31

September 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6
7 8 9 10 11 12 13
14 15 16 17 18 19 20
21 22 23 24 25 26 27
28 29 30

October 2026

Mo Tu We Th Fr Sa Su
1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31

Press releases published on September 24, 2026

Avaí Bio and Austrianova Present Encapsulated Cell Approach to Sustained α-Klotho Delivery at 2026 Klotho Conference
Sep. 24, 2026

Avaí Bio and Austrianova Present Encapsulated Cell Approach to Sustained α-Klotho Delivery at 2026 Klotho Conference

Indeterminate GlobeNewswire
Replacing decommissioned renewables will take solar and wind installations to new heights as 2.5 TW of projects reach end of life by the 2040s
Sep. 24, 2026

Replacing decommissioned renewables will take solar and wind installations to new heights as 2.5 TW of projects reach end of life by the 2040s

Indeterminate GlobeNewswire
UNITARIAN ORGANIZATION’S GLOBAL LEADERSHIP ON THE MOVE
Sep. 24, 2026

UNITARIAN ORGANIZATION’S GLOBAL LEADERSHIP ON THE MOVE

Indeterminate EIN Presswire
Terra Innovatum Welcomes Italy’s Historic Return to Nuclear Energy
Sep. 24, 2026

Terra Innovatum Welcomes Italy’s Historic Return to Nuclear Energy

Indeterminate GlobeNewswire
Boehringer Ingelheim and WHO Foundation launch global collaboration to close the gap in obesity and metabolic health
Sep. 24, 2026

Boehringer Ingelheim and WHO Foundation launch global collaboration to close the gap in obesity and metabolic health

Indeterminate GlobeNewswire
Milestone Pharmaceuticals Enrolls First Canadian Study Participant in ReVeRA-301 Phase 3 Pivotal Trial Evaluating Etripamil Nasal Spray for AFib-RVR
Sep. 24, 2026

Milestone Pharmaceuticals Enrolls First Canadian Study Participant in ReVeRA-301 Phase 3 Pivotal Trial Evaluating Etripamil Nasal Spray for AFib-RVR

Indeterminate GlobeNewswire
Marea Therapeutics, a Subsidiary of Lisata Therapeutics, Announces Upcoming Late-Breaking Presentation of MAR001 Clinical Data at the American Heart Association Scientific Sessions 2026
Sep. 24, 2026

Marea Therapeutics, a Subsidiary of Lisata Therapeutics, Announces Upcoming Late-Breaking Presentation of MAR001 Clinical Data at the American Heart Association Scientific Sessions 2026

Indeterminate GlobeNewswire
Whitetip Investments Marks 10 Years of Regulation, Transparency & Responsible Trading
Sep. 24, 2026

Whitetip Investments Marks 10 Years of Regulation, Transparency & Responsible Trading

Indeterminate GlobeNewswire
Dynacor Advances Expansion Projects, Ecuador Plant Rehabilitation 65% Complete
Sep. 24, 2026

Dynacor Advances Expansion Projects, Ecuador Plant Rehabilitation 65% Complete

Indeterminate GlobeNewswire
Dynacor poursuit ses projets d’expansion, la réfection de l’usine en Équateur est achevée à 65 %
Sep. 24, 2026

Dynacor poursuit ses projets d’expansion, la réfection de l’usine en Équateur est achevée à 65 %

Indeterminate GlobeNewswire
DEEP SEA MINERALS CORP. WELCOMES U.S. DEPARTMENT OF THE INTERIOR COMMENTS ON DEEP SEA MINERAL PERMITTING
Sep. 24, 2026

DEEP SEA MINERALS CORP. WELCOMES U.S. DEPARTMENT OF THE INTERIOR COMMENTS ON DEEP SEA MINERAL PERMITTING

Indeterminate GlobeNewswire
B2B Marketing Launches Propolis AI, a Specialist Intelligence Platform for B2B Marketers
Sep. 24, 2026

B2B Marketing Launches Propolis AI, a Specialist Intelligence Platform for B2B Marketers

Indeterminate GlobeNewswire
Coave Therapeutics to Present New Data on Wet AMD Gene Therapy Program at 26th Euretina Congress as it Advances towards the Clinic
Sep. 24, 2026

Coave Therapeutics to Present New Data on Wet AMD Gene Therapy Program at 26th Euretina Congress as it Advances towards the Clinic

Indeterminate GlobeNewswire
Pasqal Reports First Half 2026 Financial Results
Sep. 24, 2026

Pasqal Reports First Half 2026 Financial Results

Indeterminate GlobeNewswire
Medicenna Announces Oral Presentation of New Bizaxofusp Results in Recurrent Glioblastoma at the 2026 Society for Neuro-Oncology Annual Meeting
Sep. 24, 2026

Medicenna Announces Oral Presentation of New Bizaxofusp Results in Recurrent Glioblastoma at the 2026 Society for Neuro-Oncology Annual Meeting

Indeterminate GlobeNewswire
Vistagen Reports Positive Findings Supporting Fasedienol’s Potential in Very Severe Social Anxiety Disorder
Sep. 24, 2026

Vistagen Reports Positive Findings Supporting Fasedienol’s Potential in Very Severe Social Anxiety Disorder

Indeterminate GlobeNewswire
Ligand and AvenCell Therapeutics Enter Financing Agreement to Advance Pipeline of Next-Generation CAR-T Therapies for Up to $47 Million
Sep. 24, 2026

Ligand and AvenCell Therapeutics Enter Financing Agreement to Advance Pipeline of Next-Generation CAR-T Therapies for Up to $47 Million

Indeterminate GlobeNewswire
GoldInxs Advances Fishpot Toward Maiden Drill Program with New 3D IP Survey, Magnetic and Virtual DRILL™ Results
Sep. 24, 2026

GoldInxs Advances Fishpot Toward Maiden Drill Program with New 3D IP Survey, Magnetic and Virtual DRILL™ Results

Indeterminate GlobeNewswire
Mesoblast Receives FDA Approval for New Potency Assay to Release Commercial Ryoncil Product
Sep. 24, 2026

Mesoblast Receives FDA Approval for New Potency Assay to Release Commercial Ryoncil Product

Indeterminate GlobeNewswire
B2B Marketing Launches Propolis AI, a Specialist Intelligence Platform for B2B Marketers
Sep. 24, 2026

B2B Marketing Launches Propolis AI, a Specialist Intelligence Platform for B2B Marketers

Indeterminate GlobeNewswire
Show More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

European Morning Report

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.